Author:
Pei Shiyao,Yuan Xi,Zhang Zhimin,Yao Run,Xie Yubin,Shen Minxue,Li Bijuan,Chen Xiang,Yin Mingzhu
Abstract
AbstractThe COVID-19 is currently spreading around the world, which has posed significant threats to global health and economy. Convalescent plasma is confirmed effective against the novel corona virus in preliminary studies. In this paper, we first described the therapeutic schedule, antibody detection method, indications, contraindications of the convalescent plasmas, and reported the operability of the treatment by case study.
Publisher
Cold Spring Harbor Laboratory
Reference8 articles.
1. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
2. WHO. Coronavirus disease (COVID-2019) situation reports. 2020
3. COVID-19: An Update on the Epidemiological, Clinical, Preventive and Therapeutic Evidence and Guidelines of Integrative Chinese–Western Medicine for the Management of 2019 Novel Coronavirus Disease
4. Clinical treatment of COVID-19 Convalescent Plasma (the second trial edition). http://wwwnhcgovcn/yzygj/s7658/202003/61d608a7e8bf49fca418a6074c2bf5a2shtml
5. FDA. Investigational covid-19 convalescent plasma-emergency INDs. https://www.fda.gov/vaccines-blood-biologics/investigational-new-drug-ind-or-device-exemption-ideprocess-cber/investigational-covid-19-convalescent-plasma-emergency-inds.
Cited by
28 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献